Rybelsus 7 mg Tablets – 30 Tablets

Description

Rybelsus contains Semaglutide 7 mg, an oral GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes mellitus alongside diet and exercise.

Semaglutide helps stimulate insulin release when blood glucose levels are elevated, reduces glucagon secretion, and slows gastric emptying, helping improve blood sugar control and supporting weight management in some patients.

Key Benefits

• Contains Semaglutide 7 mg
• Once-daily oral tablet
• Helps improve blood glucose control
• GLP-1 receptor agonist
• Supports HbA1c reduction
• May assist with weight management
• Suitable for adults with type 2 diabetes
• Pack contains 30 tablets

Indications

• Type 2 diabetes mellitus.
• Improvement of glycemic control.
• Used alongside diet and exercise.
• Part of a physician-directed diabetes management plan.

Directions for Use

• Use exactly as prescribed by your physician.
• Take once daily on an empty stomach.
• Swallow with a small amount of water.
• Wait at least 30 minutes before eating, drinking, or taking other medications.
• Swallow the tablet whole.

Active Ingredient

Semaglutide 7 mg

Warnings

• Prescription-only medicine.
• Not indicated for type 1 diabetes.
• Not for diabetic ketoacidosis.
• Inform your physician if you have pancreatic or kidney disorders.
• Monitor blood glucose regularly.
• Keep out of reach of children.

Possible Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Reduced appetite
• Indigestion

Product Details

Brand: Rybelsus

Active Ingredient: Semaglutide

Strength: 7 mg

Dosage Form: Tablets

Pack Size: 30 Tablets

Category: Type 2 Diabetes Medication